Compare Medtronic PLC (MDT) vs Schwab US Large Cap Growth ETF (SCHG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs Schwab US Large Cap Growth ETF — how do they compare? Medtronic PLC trades at $82.49 (market cap $106.61B), while Schwab US Large Cap Growth ETF trades at $34.28. The key difference: Medtronic PLC pays a 3.46% dividend while Schwab US Large Cap Growth ETF pays none, and Schwab US Large Cap Growth ETF is trading nearer its 52-week high, Medtronic PLC nearer its low. Which is the better fit depends on your goals.
| MDT | SCHG | |
|---|---|---|
Market Cap | $106.61B | — |
Sector | Health | Sector/Thematic |
52-Week High | $105.35 | $35.30 |
52-Week Low | $73.75 | $28.10 |
Enterprise Value | $125.36B | — |
Dividend Yield | 3.46% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.
The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.
SCHG trades at $34.15, down slightly by 0.09% today, with a bullish technical signal driven by moving averages. The ETF offers concentrated exposure to large-cap U.S. growth stocks, particularly in technology and AI, with a low 0.04% expense ratio. Recent news highlights strong fundamentals and AI-driven growth potential, though heavy concentration in top holdings like Nvidia, Apple, and Microsoft presents both opportunity and risk.
Outlook remains positive for long-term growth investors, supported by AI capital expenditure trends and low costs. Key risks include high valuation sensitivity, interest rate impacts, and lack of diversification. Analyst sentiment is mixed, with some caution on recent underperformance versus broader markets despite strong thematic tailwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About Schwab US Large Cap Growth ETF
SCHG is an ETF that seeks to track the total return of the Dow Jones U.S. Large-Cap Growth Total Stock Market Index. The fund provides low-cost exposure to a diversified portfolio of large-capitalization U.S. companies that are classified as growth stocks based on factors such as sales, earnings, and book value growth rates. SCHG is often used by investors seeking long-term capital appreciation from market-leading companies with above-average growth potential.
Read more on SCHG →
